2021 annual financial data
Atara Biotherapeutics 2021 Operating cash flow margin
Direct answer
Operating cash flow margin was -1,084.18%.
Operating income was -340,462,000 USD and net income was -340,141,000 USD.
Operating cash flow was -220,522,000 USD.
Get free Atara Biotherapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 20,340,000 USD
- Operating income
- -340,462,000 USD
- Net income
- -340,141,000 USD
- Operating cash flow
- -220,522,000 USD